top of page
OK.jpg

IN THE STATES

OKLAHOMA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in Oklahoma.

OK.png

Economic
Output

$4.3B

Direct Jobs Supported by the Industry

3,044

Total Jobs Supported

15,436

State Total Vendor Relationships

195

State Total Vendor Spending

$129,652,451

Total Clinical
Trials

417

Dollar Amount Invested

$113.1M

Clinical Trial Participants

6,982

Total Economic Impact

$286.4M

bottom of page